235 related articles for article (PubMed ID: 25329832)
41. [Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models].
Niu ZS; Bai FL; Sun T; Tian H; Yin JC; Cao HW; Yu D; Tian GY; Wu YZ; Li DS; Ren GP
Yao Xue Xue Bao; 2014 Mar; 49(3):310-5. PubMed ID: 24961100
[TBL] [Abstract][Full Text] [Related]
42. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
Viruses; 2020 May; 12(5):. PubMed ID: 32397134
[TBL] [Abstract][Full Text] [Related]
43. Cessation of blood-to-brain influx of interleukin-15 during development of EAE.
Hsuchou H; Pan W; Wu X; Kastin AJ
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1568-78. PubMed ID: 19536071
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.
Ochoa MC; Minute L; López A; Pérez-Ruiz E; Gomar C; Vasquez M; Inoges S; Etxeberria I; Rodriguez I; Garasa S; Mayer JA; Wirtz P; Melero I; Berraondo P
Oncoimmunology; 2018; 7(2):e1393597. PubMed ID: 29308327
[TBL] [Abstract][Full Text] [Related]
45. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.
Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL
Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686
[TBL] [Abstract][Full Text] [Related]
46. M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
Pisklakova A; McKenzie B; Zemp F; Lun X; Kenchappa RS; Etame AB; Rahman MM; Reilly K; Pilon-Thomas S; McFadden G; Kurz E; Forsyth PA
Neuro Oncol; 2016 Aug; 18(8):1088-1098. PubMed ID: 26962017
[TBL] [Abstract][Full Text] [Related]
47. IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy.
Beha N; Harder M; Ring S; Kontermann RE; Müller D
Mol Cancer Ther; 2019 Jul; 18(7):1278-1288. PubMed ID: 31040163
[TBL] [Abstract][Full Text] [Related]
48. The expression levels of CHI3L1 and IL15Rα correlate with TGM2 in duodenum biopsies of patients with celiac disease.
Catrogiovanni P; Musumeci G; Giunta S; Imbesi R; Di Rosa M
Inflamm Res; 2020 Sep; 69(9):925-935. PubMed ID: 32500186
[TBL] [Abstract][Full Text] [Related]
49. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-15 receptor is essential to facilitate GABA transmission and hippocampal-dependent memory.
He Y; Hsuchou H; Wu X; Kastin AJ; Khan RS; Pistell PJ; Wang WH; Feng J; Li Z; Guo X; Pan W
J Neurosci; 2010 Mar; 30(13):4725-34. PubMed ID: 20357123
[TBL] [Abstract][Full Text] [Related]
51. Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.
Ng SSM; Nagy BA; Jensen SM; Hu X; Alicea C; Fox BA; Felber BK; Bergamaschi C; Pavlakis GN
Clin Cancer Res; 2017 Jun; 23(11):2817-2830. PubMed ID: 27986749
[No Abstract] [Full Text] [Related]
52. Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.
Torres-Domínguez LE; de Matos AL; Rahman MM; McFadden G
Methods Mol Biol; 2021; 2225():63-75. PubMed ID: 33108657
[TBL] [Abstract][Full Text] [Related]
53. IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis.
Yang Y; Zhang XM; Zhang N; Cheng L; Li C; Zhang S; Zhang JF; Dai L; Tian HW; Yan N; Fan P; Dai LX; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
Cancer Gene Ther; 2012 Jul; 19(7):460-7. PubMed ID: 22539063
[TBL] [Abstract][Full Text] [Related]
54. Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
Stanford MM; Barrett JW; Gilbert PA; Bankert R; McFadden G
J Virol; 2007 Nov; 81(22):12704-8. PubMed ID: 17728229
[TBL] [Abstract][Full Text] [Related]
55. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance.
Doedens AL; Rubinstein MP; Gross ET; Best JA; Craig DH; Baker MK; Cole DJ; Bui JD; Goldrath AW
Cancer Immunol Res; 2016 Sep; 4(9):799-811. PubMed ID: 27485135
[TBL] [Abstract][Full Text] [Related]
56. Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells.
Ye JF; Lin YQ; Yu XH; Liu MY; Li Y
Int Immunopharmacol; 2016 Sep; 38():460-7. PubMed ID: 27380620
[TBL] [Abstract][Full Text] [Related]
57. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.
Josiah DT; Zhu D; Dreher F; Olson J; McFadden G; Caldas H
Mol Ther; 2010 Feb; 18(2):377-85. PubMed ID: 19904233
[TBL] [Abstract][Full Text] [Related]
58. IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis.
Yu JJ; Sun HT; Zhang ZF; Shi RX; Liu LB; Shang WQ; Wei CY; Chang KK; Shao J; Wang MY; Li MQ
Reproduction; 2016 Aug; 152(2):151-60. PubMed ID: 27190213
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.
Wu X; Hsuchou H; Kastin AJ; He Y; Khan RS; Stone KP; Cash MS; Pan W
Psychoneuroendocrinology; 2011 Feb; 36(2):266-78. PubMed ID: 20724079
[TBL] [Abstract][Full Text] [Related]
60. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion.
Schreiber M; McFadden G
Virology; 1994 Nov; 204(2):692-705. PubMed ID: 7941338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
